Clinical trials
Phase 2 Communicable Diseases trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| 101 Therapeutics | 1 |
| 60P Australia Pty Ltd | 1 |
| National Center for Research Resources (NCRR) | 1 |
| Nuron Biotech Inc. | 1 |
| Singapore General Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Communicable Diseases | 5 |
| Arthritis | 1 |
| COVID-19 | 1 |
| Connective Tissue Diseases | 1 |
| Cytokine Release Syndrome | 1 |
| Encephalitis, Japanese | 1 |
| Immune System Diseases | 1 |
| Inflammation | 1 |
| Lupus Erythematosus, Systemic | 1 |
| Rare Diseases | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.